Factors predicting the acceptance of herpes simplex virus type 2 antibody testing among adolescents and young adults

Gregory Zimet, Susan L. Rosenthal, J. Fortenberry, Rebecca C. Brady, Wanzhu Tu, Jingwei Wu, David I. Bernstein, Lawrence R. Stanberry, Katherine M. Stone, Jami S. Leichliter, Kenneth Fife

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Background: The rates and determinants of acceptance of herpes simplex virus type 2 (HSV-2) testing have not been adequately studied. Objectives: The objective of this study was to identify factors associated with acceptance of HSV-2 antibody testing in individuals with no history of genital herpes. Study: We conducted a cross-sectional survey study followed by the offer of free HSV-2 serologic testing at an urban sexually transmitted disease (STD) clinic, 2 general adult medical clinics, an urban university campus, and an urban adolescent medicine clinic. A total of 1199 individuals aged 14 to 30 years completed the survey and were offered testing. Results: A total of 68.4% accepted HSV-2 testing. Factors independently associated with acceptance were female sex, older age, having an STD history, having 1 or more sexual partners in the last 6 months, perceived vulnerability to HSV-2 infection, and perceived benefits of HSV-2 testing. Fear of needles predicted rejection of testing, as did attending a general medical clinic versus an STD clinic and nonwhite race. Conclusion: There is a substantial interest in HSV-2 antibody testing across a variety of settings. Those at greatest behavioral and historic risk for HSV-2 infection, women, and persons whose health beliefs are consistent with testing are more likely to accept serologic testing when it is offered.

Original languageEnglish
Pages (from-to)665-669
Number of pages5
JournalSexually Transmitted Diseases
Volume31
Issue number11
DOIs
StatePublished - Nov 2004

Fingerprint

Human Herpesvirus 2
Young Adult
Antibodies
Sexually Transmitted Diseases
Virus Diseases
Cross-Sectional Studies
Adolescent Medicine
Herpes Genitalis
Sexual Partners
Fear
Needles
Health

ASJC Scopus subject areas

  • Dermatology
  • Public Health, Environmental and Occupational Health
  • Microbiology (medical)

Cite this

Factors predicting the acceptance of herpes simplex virus type 2 antibody testing among adolescents and young adults. / Zimet, Gregory; Rosenthal, Susan L.; Fortenberry, J.; Brady, Rebecca C.; Tu, Wanzhu; Wu, Jingwei; Bernstein, David I.; Stanberry, Lawrence R.; Stone, Katherine M.; Leichliter, Jami S.; Fife, Kenneth.

In: Sexually Transmitted Diseases, Vol. 31, No. 11, 11.2004, p. 665-669.

Research output: Contribution to journalArticle

Zimet, Gregory ; Rosenthal, Susan L. ; Fortenberry, J. ; Brady, Rebecca C. ; Tu, Wanzhu ; Wu, Jingwei ; Bernstein, David I. ; Stanberry, Lawrence R. ; Stone, Katherine M. ; Leichliter, Jami S. ; Fife, Kenneth. / Factors predicting the acceptance of herpes simplex virus type 2 antibody testing among adolescents and young adults. In: Sexually Transmitted Diseases. 2004 ; Vol. 31, No. 11. pp. 665-669.
@article{5ae5359450554853a45b5509a326f8a3,
title = "Factors predicting the acceptance of herpes simplex virus type 2 antibody testing among adolescents and young adults",
abstract = "Background: The rates and determinants of acceptance of herpes simplex virus type 2 (HSV-2) testing have not been adequately studied. Objectives: The objective of this study was to identify factors associated with acceptance of HSV-2 antibody testing in individuals with no history of genital herpes. Study: We conducted a cross-sectional survey study followed by the offer of free HSV-2 serologic testing at an urban sexually transmitted disease (STD) clinic, 2 general adult medical clinics, an urban university campus, and an urban adolescent medicine clinic. A total of 1199 individuals aged 14 to 30 years completed the survey and were offered testing. Results: A total of 68.4{\%} accepted HSV-2 testing. Factors independently associated with acceptance were female sex, older age, having an STD history, having 1 or more sexual partners in the last 6 months, perceived vulnerability to HSV-2 infection, and perceived benefits of HSV-2 testing. Fear of needles predicted rejection of testing, as did attending a general medical clinic versus an STD clinic and nonwhite race. Conclusion: There is a substantial interest in HSV-2 antibody testing across a variety of settings. Those at greatest behavioral and historic risk for HSV-2 infection, women, and persons whose health beliefs are consistent with testing are more likely to accept serologic testing when it is offered.",
author = "Gregory Zimet and Rosenthal, {Susan L.} and J. Fortenberry and Brady, {Rebecca C.} and Wanzhu Tu and Jingwei Wu and Bernstein, {David I.} and Stanberry, {Lawrence R.} and Stone, {Katherine M.} and Leichliter, {Jami S.} and Kenneth Fife",
year = "2004",
month = "11",
doi = "10.1097/01.olq.0000143089.77493.c2",
language = "English",
volume = "31",
pages = "665--669",
journal = "Sexually Transmitted Diseases",
issn = "0148-5717",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - Factors predicting the acceptance of herpes simplex virus type 2 antibody testing among adolescents and young adults

AU - Zimet, Gregory

AU - Rosenthal, Susan L.

AU - Fortenberry, J.

AU - Brady, Rebecca C.

AU - Tu, Wanzhu

AU - Wu, Jingwei

AU - Bernstein, David I.

AU - Stanberry, Lawrence R.

AU - Stone, Katherine M.

AU - Leichliter, Jami S.

AU - Fife, Kenneth

PY - 2004/11

Y1 - 2004/11

N2 - Background: The rates and determinants of acceptance of herpes simplex virus type 2 (HSV-2) testing have not been adequately studied. Objectives: The objective of this study was to identify factors associated with acceptance of HSV-2 antibody testing in individuals with no history of genital herpes. Study: We conducted a cross-sectional survey study followed by the offer of free HSV-2 serologic testing at an urban sexually transmitted disease (STD) clinic, 2 general adult medical clinics, an urban university campus, and an urban adolescent medicine clinic. A total of 1199 individuals aged 14 to 30 years completed the survey and were offered testing. Results: A total of 68.4% accepted HSV-2 testing. Factors independently associated with acceptance were female sex, older age, having an STD history, having 1 or more sexual partners in the last 6 months, perceived vulnerability to HSV-2 infection, and perceived benefits of HSV-2 testing. Fear of needles predicted rejection of testing, as did attending a general medical clinic versus an STD clinic and nonwhite race. Conclusion: There is a substantial interest in HSV-2 antibody testing across a variety of settings. Those at greatest behavioral and historic risk for HSV-2 infection, women, and persons whose health beliefs are consistent with testing are more likely to accept serologic testing when it is offered.

AB - Background: The rates and determinants of acceptance of herpes simplex virus type 2 (HSV-2) testing have not been adequately studied. Objectives: The objective of this study was to identify factors associated with acceptance of HSV-2 antibody testing in individuals with no history of genital herpes. Study: We conducted a cross-sectional survey study followed by the offer of free HSV-2 serologic testing at an urban sexually transmitted disease (STD) clinic, 2 general adult medical clinics, an urban university campus, and an urban adolescent medicine clinic. A total of 1199 individuals aged 14 to 30 years completed the survey and were offered testing. Results: A total of 68.4% accepted HSV-2 testing. Factors independently associated with acceptance were female sex, older age, having an STD history, having 1 or more sexual partners in the last 6 months, perceived vulnerability to HSV-2 infection, and perceived benefits of HSV-2 testing. Fear of needles predicted rejection of testing, as did attending a general medical clinic versus an STD clinic and nonwhite race. Conclusion: There is a substantial interest in HSV-2 antibody testing across a variety of settings. Those at greatest behavioral and historic risk for HSV-2 infection, women, and persons whose health beliefs are consistent with testing are more likely to accept serologic testing when it is offered.

UR - http://www.scopus.com/inward/record.url?scp=7044264372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7044264372&partnerID=8YFLogxK

U2 - 10.1097/01.olq.0000143089.77493.c2

DO - 10.1097/01.olq.0000143089.77493.c2

M3 - Article

VL - 31

SP - 665

EP - 669

JO - Sexually Transmitted Diseases

JF - Sexually Transmitted Diseases

SN - 0148-5717

IS - 11

ER -